Publications by authors named "Dawn E Telford"

20Publications

Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr mice.

Atherosclerosis 2019 07 9;286:60-70. Epub 2019 May 9.

Molecular Medicine, Robarts Research Institute, The University of Western Ontario, 1151 Richmond St N., London, Ontario, N6A 5B7, Canada; Department of Biochemistry, The University of Western Ontario, 1151 Richmond St N., London, Ontario, N6A 5B7, Canada; Department of Medicine, The University of Western Ontario, 1151 Richmond St N., London, Ontario, N6A 5B7, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00219150193041
Publisher Site
http://dx.doi.org/10.1016/j.atherosclerosis.2019.05.009DOI Listing
July 2019

Naringenin Supplementation to a Chow Diet Enhances Energy Expenditure and Fatty Acid Oxidation, and Reduces Adiposity in Lean, Pair-Fed Ldlr Mice.

Mol Nutr Food Res 2019 03 2;63(6):e1800833. Epub 2019 Jan 2.

Molecular Medicine, Robarts Research Institute, The University of Western Ontario, 1151 Richmond St N., London, Ontario, N6A 5B7, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mnfr.201800833DOI Listing
March 2019

Bempedoic Acid Lowers Low-Density Lipoprotein Cholesterol and Attenuates Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient ( and ) Yucatan Miniature Pigs.

Arterioscler Thromb Vasc Biol 2018 05 15;38(5):1178-1190. Epub 2018 Feb 15.

From the Robarts Research Institute (A.C.B., D.E.T., B.G.S., J.Y.E., C.G.S., J.G.P., M.W.H.)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.117.310676DOI Listing
May 2018

Prevention of Diet-Induced Metabolic Dysregulation, Inflammation, and Atherosclerosis in Mice by Treatment With the ATP-Citrate Lyase Inhibitor Bempedoic Acid.

Arterioscler Thromb Vasc Biol 2017 04 2;37(4):647-656. Epub 2017 Feb 2.

From the Molecular Medicine Research Laboratory, Robarts Research Institute (J.P.S., A.C.B., B.G.S., D.E.T., C.G.S., J.Y.E., M.W.H.), Department of Biochemistry (J.P.S., A.C.B., M.W.H.), and Department of Medicine (D.E.T., C.G.S., J.Y.E., M.W.H.), The University of Western Ontario, London, Canada; and Esperion Therapeutics Inc, Ann Arbor, MI (S.L.P., R.S.N.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.116.308963DOI Listing
April 2017

Naringenin prevents obesity, hepatic steatosis, and glucose intolerance in male mice independent of fibroblast growth factor 21.

Endocrinology 2015 Jun 16;156(6):2087-102. Epub 2015 Mar 16.

Department of Vascular Biology (J.M.A., E.E.M., A.C.B., B.G.S., D.E.T., S.S.C., C.G.S., M.W.H.) and Imaging Research Laboratories (M.D.), Robarts Research Institute, London, Ontario, Canada N6A 5B7; Children's Health Research Institute and Departments of Paediatrics, Physiology and Pharmacology, and Oncology (C.L.P.); Departments of Biochemistry (J.M.A., E.E.M., A.C.B., S.S.C., M.W.H.), Medical Biophysics (M.D.) and Medicine (D.E.T., C.G.S., M.W.H.), The University of Western Ontario, London, Ontario, Canada N6A 5B7; and Lilly Research Laboratories (A.C.A., A.K.), Division of Eli Lilly and Company, Indianapolis, Indiana 46285.

View Article

Download full-text PDF

Source
https://academic.oup.com/endo/article-lookup/doi/10.1210/en.
Publisher Site
http://dx.doi.org/10.1210/en.2014-2003DOI Listing
June 2015

PPARδ activation attenuates hepatic steatosis in Ldlr-/- mice by enhanced fat oxidation, reduced lipogenesis, and improved insulin sensitivity.

J Lipid Res 2014 07 26;55(7):1254-66. Epub 2014 May 26.

Vascular Biology, Robarts Research Institute, The University of Western Ontario, London, Ontario, Canada, N6A 5B7 Departments of Biochemistry, The University of Western Ontario, London, Ontario, Canada, N6A 5B7 Medicine, The University of Western Ontario, London, Ontario, Canada, N6A 5B7.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.M046037DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4076091PMC
July 2014

Peroxisome proliferator-activated receptor δ agonist GW1516 attenuates diet-induced aortic inflammation, insulin resistance, and atherosclerosis in low-density lipoprotein receptor knockout mice.

Arterioscler Thromb Vasc Biol 2014 Jan 24;34(1):52-60. Epub 2013 Oct 24.

From the Department of Vascular Biology, Robarts Research Institute (L.A.B., A.C.B., S.S.C., D.E.T., B.G.S., J.Y.E., C.G.S., H.Y., J.G.P., M.W.H.), London, Ontario, Canada; and Departments of Biochemistry (L.A.B., A.C.B., S.S.C., J.G.P., M.W.H.), Medicine (D.E.T., J.Y.E., C.G.S., R.G.T., J.G.P., M.W.H.), and Physiology and Pharmacology (R.G.T.), The University of Western Ontario, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.113.301830DOI Listing
January 2014

Activation of peroxisome proliferator-activated receptor δ inhibits human macrophage foam cell formation and the inflammatory response induced by very low-density lipoprotein.

Arterioscler Thromb Vasc Biol 2012 Dec 27;32(12):2919-28. Epub 2012 Sep 27.

Vascular Biology, Robarts Research Institute, Department of Biochemistry, The University of Western Ontario, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/ATVBAHA.112.255208DOI Listing
December 2012

The molecular mechanisms underlying the reduction of LDL apoB-100 by ezetimibe plus simvastatin.

J Lipid Res 2007 Mar 27;48(3):699-708. Epub 2006 Nov 27.

Vascular Biology, Robarts Research Institute, The University of Western Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.M600439-JLR200DOI Listing
March 2007

The ACAT inhibitor avasimibe increases the fractional clearance rate of postprandial triglyceride-rich lipoproteins in miniature pigs.

Biochim Biophys Acta 2005 Dec 22;1738(1-3):10-8. Epub 2005 Dec 22.

Department of Core Clinical Pathology and Biochemistry, Pathwest Laboratory Medicine WA, Royal Perth Hospital and School of Medicine and Pharmacology, University of Western Australia, Perth, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bbalip.2005.11.010DOI Listing
December 2005

Lord of the rings--the mechanism for oxidosqualene:lanosterol cyclase becomes crystal clear.

Trends Pharmacol Sci 2005 Jul;26(7):335-40

Robarts Research Institute, Vascular Biology Group, Departments of Medicine and Biochemistry, The University of Western Ontario, London, Ontario N6A 5K8, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.tips.2005.05.004DOI Listing
July 2005

Inhibition of both the apical sodium-dependent bile acid transporter and HMG-CoA reductase markedly enhances the clearance of LDL apoB.

J Lipid Res 2003 May 1;44(5):943-52. Epub 2003 Feb 1.

Robarts Research Institute and Departments of Medicine and Biochemistry, University of Western Ontario, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1194/jlr.M200482-JLR200DOI Listing
May 2003

Inhibition of the apical sodium-dependent bile acid transporter reduces LDL cholesterol and apoB by enhanced plasma clearance of LDL apoB.

Arterioscler Thromb Vasc Biol 2002 Nov;22(11):1884-91

Department of Medicine and Biochemistry and The John P. Robarts Research Institute, The University of Western Ontario, London, Ontario, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1161/01.atv.0000035390.87288.26DOI Listing
November 2002